DIAZEPAM solution Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

diazepam solution

pharmaceutical associates, inc. - diazepam (unii: q3jtx2q7tu) (diazepam - unii:q3jtx2q7tu) - diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. in acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma); spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; and stiff-man syndrome. oral diazepam may be used adjunctively in convulsive disorders, although it has not proved useful as the sole therapy. the effectiveness of diazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug

LOKELMA 10 G Israel - Tiếng Anh - Ministry of Health

lokelma 10 g

astrazeneca (israel) ltd - sodium zirconium cyclosilicate - powder for suspension - sodium zirconium cyclosilicate 10 g/sachet - sodium zirconium cyclosilicate - lokelma is indicated for the treatment of hyperkalaemia in adult patients

LOKELMA 5 G Israel - Tiếng Anh - Ministry of Health

lokelma 5 g

astrazeneca (israel) ltd - sodium zirconium cyclosilicate - powder for suspension - sodium zirconium cyclosilicate 5 g/sachet - sodium zirconium cyclosilicate - lokelma is indicated for the treatment of hyperkalaemia in adult patients

Radiation therapy bolus, reusable Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

radiation therapy bolus, reusable

nl-tec pty ltd - 58022 - radiation therapy bolus, reusable - a pliable solid non sterile material that has the properties of skin when irradiated and is intended to be applied to the skin to modify radiation dose at the skin surface or depth. it is available in various static thicknesses (e.g. 0.5 to 4.0 cm) which may be cut by the operator to provide a reproducible radiation beam modifier for a prescribed dose depth during treatment of a particular site and disease. this is a reusable device.

Radiation therapy bolus, reusable Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

radiation therapy bolus, reusable

calvary health care newcastle ltd - 58022 - radiation therapy bolus, reusable - radiotherapy bolus is a pliable, solid, non-sterile material that has similar properties to water when irradiated and is intended to be applied to the skin to modify radiation dose at the skin surface or depth. in rare cases the material may also be placed in the patient?s mouth to form a separator between cheek and teeth. it is designed to provide a reproducible radiation beam modifier during treatment of a particular site and disease. it is made of thermoplastic, dental wax, gel or paraffin. paraffin bolus is layered onto gauze bandage in multiple layers, then covered in clingwrap. "jel" is a firm gel bolus available in various thicknesses (e.g., 0.5 to 4.0 cm), which may be cut to the desired size and shape. thermoplastic and dental wax bolus are melted or softened into the required shape and then cooled and set. bolus may be covered in clingwrap during treatment. the bolus may be shaped to fit an individual patient during their radiotherapy course, or made in a generic shape and thickness which may be used by multiple patients.

Radiation therapy bolus, reusable Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

radiation therapy bolus, reusable

nl-tec pty ltd - 58022 - radiation therapy bolus, reusable - intended to be applied to the skin to modify radiation dose at the skin surface. it is available in various static thicknesses which may be cut by the operator, to provide a reproducible radiation beam modifier for a prescribed dose depth during treatment of a particular site and disease.

DIAZEPAM solution Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

diazepam solution

major pharmaceuticals - diazepam (unii: q3jtx2q7tu) (diazepam - unii:q3jtx2q7tu) - diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. in acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia), athetosis, and stiff-man syndrome. oral diazepam may be used adjunctively in convulsive disorders, although it has not proved useful as the sole therapy. the effectiveness of diazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug

SUPREMINE ER phentermine (as hydrochloride) 40 mg extended release tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

supremine er phentermine (as hydrochloride) 40 mg extended release tablet blister pack

juno pc holdings pty limited - phentermine hydrochloride, quantity: 49.7 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; polyvinyl alcohol; macrogol 3350; brilliant scarlet 4r aluminium lake - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

SUPREMINE ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

supremine er phentermine (as hydrochloride) 30 mg extended release tablet blister pack

juno pc holdings pty limited - phentermine hydrochloride, quantity: 37.275 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; ferrosoferric oxide - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.

SUPREMINE ER phentermine (as hydrochloride) 15 mg extended release tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

supremine er phentermine (as hydrochloride) 15 mg extended release tablet blister pack

juno pc holdings pty limited - phentermine hydrochloride, quantity: 18.6375 mg - tablet, modified release - excipient ingredients: cetostearyl alcohol; sorbitol; maltodextrin; stearic acid; magnesium stearate; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; iron oxide yellow; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - phentermine is an anorectic agent indicated in the management of obesity as a short-term adjunct in a medically monitored comprehensive regimen of weight reduction based, for example, on exercise, diet (caloric/kilojoule restriction) and behaviour modification in obese patients with a body mass index (bmi) of 30 kg/m2 or greater.,the treatment with phentermine can be initiated in overweight patients with a lower bmi (25 to 29.9 kg/m2), which increases the risk of morbidity from a number of disorders. secondary organic causes of obesity should be excluded by diagnosis before prescribing this agent.